Search - tctmd.com

Displaying 881 - 900 of 1038

Sort: Relevancy | Date

News Conference News AHA 2014

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Yael L. Maxwell

November 16, 2014

News Daily News

Study Highlights Clinical Risk of Nonobstructive CAD

November 06, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: Neal S. Kleiman

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Frederick Kushner

September 17, 2014

Presentation TCT 2014

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Presenter: Roxana Mehran, Harvey D. White, Yaling Han

September 15, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

News Daily News

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

L.A. McKeown

September 11, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

Pre-AMI Ischemia May Reduce Early Mortality

July 24, 2014

News Daily News

STREAM Substudy: Lytic Failure Means Worse Outcomes for Pharmacoinvasively Treated STEMI Patients

July 17, 2014

News Daily News

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

Yael L. Maxwell

July 17, 2014

News Daily News

STREAM Substudy: Aborted STEMI More Common with Strategy of Early Fibrinolysis

June 27, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

Advertisement

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Study Highlights Clinical Risk of Nonobstructive CAD

Thoughtful Insights

Case Presentation

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

Pre-AMI Ischemia May Reduce Early Mortality

STREAM Substudy: Lytic Failure Means Worse Outcomes for Pharmacoinvasively Treated STEMI Patients

HEAT-PPCI Published: Discrepant Finding of Heparin’s Superiority over Bivalirudin in Primary PCI Still Puzzles

STREAM Substudy: Aborted STEMI More Common with Strategy of Early Fibrinolysis

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content